Come up with a name for your new list and we'll add to it:
Viamet Pharmaceuticals raised a round of funding on January 03, 2018. Investors include
NovaQuest Capital Management.
Viamet Pharmaceuticals discovers and develops breakthrough therapies based on specialization in metalloenzyme chemistry and biology. The company's clinical portfolio includes novel agents to treat bot…